基于超微小ZnFe2O4纳米颗粒的新型T1造影剂的制备及应用研究

韩佳媚, 梁国海

激光生物学报 ›› 2018, Vol. 27 ›› Issue (4) : 313-319.

PDF(2400 KB)
PDF(2400 KB)
激光生物学报 ›› 2018, Vol. 27 ›› Issue (4) : 313-319.
研究论文

基于超微小ZnFe2O4纳米颗粒的新型T1造影剂的制备及应用研究

作者信息 +

Preparation and Application of Ultrasmall ZnFe2O4 NanoparticlesBased  T1  MRI Contrast Agent

Author information +
文章历史 +

摘要

非Gd型T1造影剂的开发是近年来MRI造影剂的重要研究方向。本工作通过高温热分解法制备了粒径为(3.02±0.62)nm的掺杂Zn的氧化铁纳米颗粒(ZnFe2O4),其r1弛豫度为2.5 L/(mmol·s),r2/r1比值为2.2。合成方法简便、经济,容易实现大量制备。以生物相容性的PO-PEG分子对颗粒进行修饰,使颗粒相转移至水溶液中,可保持长期稳定分散。最后,以ZnFe2O4为造影剂,对小鼠肿瘤部位进行MR成像,获得~11%的信号增强。本研究工作显示ZnFe2O4@PO-PEG具备作为高安全性非钆型T1造影剂并应用于实际MR造影成像的良好潜力。

Abstract

Nongadoliniumbased T1  contrast agents have attracted great interest in recent years. In this work, (3.02±0.62) nm zincdoped iron oxide nanoparticles (ZnFe2O4) with a high r1 relaxivity of 2.5 L/(mmol·s) and low r2/r1 ratio of 2.2 are synthesized using a onepot thermal decomposition process. The synthetic procedure is simple, cost effective, and easy to scale up. The nanoparticles are modified with a biologically compatible ligand POPEG. Due to the hydrophilic polymer coating, the particles are highly dispersible and stable in aqueous solution. Finally, we applied the nanoparticles to in vivo magnetic resonance imaging and obtained a relative signal enhancement of 11% at the tumor region. This study revealed ZnFe2O4@PO-PEG as a potential candidate for a nongadoliniumbased T1 contrast agent with extraordinary biosafety.

引用本文

导出引用
韩佳媚, 梁国海. 基于超微小ZnFe2O4纳米颗粒的新型T1造影剂的制备及应用研究[J]. 激光生物学报. 2018, 27(4): 313-319
HAN Jiamei, LIANG Guohai. Preparation and Application of Ultrasmall ZnFe2O4 NanoparticlesBased  T1  MRI Contrast Agent[J]. Acta Laser Biology Sinica. 2018, 27(4): 313-319

PDF(2400 KB)

Accesses

Citation

Detail

段落导航
相关文章

/